home

M Pharmaceutical Inc revives anti-obesity drug deal

EVENTSproactiveinvestors2016-04-07 12:53 Read   89

“This product fits into our mission of developing innovative technologies for obesity with fewer side effects than currently available products," said CEo Brian Keane.

US plays break-up artist as panic envelops Pfallergan

EVENTSEp vantage2016-04-06 12:41 Read   89

While it was unable to stop every US company from migrating overseas to lower taxes, President Obama’s Treasury Department has bagged one big pharma trophy and now has another in its sights.

Teva and Takeda appoint head of Japanese generics venture

EVENTSPLIVE2016-04-06 11:28 Read   108

Teva and Takeda have officially launched their Japanese joint venture and named Hiroshi Matsumori as its chief executive.

Entasis Announces $50 Million Series B Financing led by Clarus

EVENTSBusinesswire2016-04-05 13:42 Read   83

Entasis Therapeutics, a company focused on the discovery and development of breakthrough anti-infective products, today announced the completion of a $50 million Series B financing to advance its pipeline of clinical and preclinical products.

J&J drops NGF blocker fulranumab

EVENTSpmlive2016-04-05 12:46 Read   140

Johnson & Johnson has returned the rights to fulranumab to Amgen, raising another question mark over the role of nerve growth factor (NGF) blockers as pain therapies.

Sanofi Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round

EVENTSFierce biotech2016-03-31 13:12 Read   167

ImmuneXcite has raised $8.6 million in a Series A financing round as the immuno-oncology biotech announced the addition of Glaxo ($GSK) and Sanofi Genzyme ($SNY) veterans to its executive crew.

'Merger success' nets Allergan chief Saunders an extra $14M-plus in 2015 pay

EVENTSPharma news2016-03-30 13:45 Read   84

 Allergan CEO Brent Saunders' total pay package may look like it's dropped since 2014, thanks to some front-loaded equity awards last year. But don't worry too much--in 2015, he and his fellow Allergan execs took home hefty cash incentive payouts and "merger success" bonuses.

Gilead must pay just $200m for hep C patents, says jury

EVENTSplive2016-03-30 10:10 Read   108

Merck & Co may have won its hepatitis C patent dispute with Gilead Sciences, but subsequent court decisions have not gone its way.

South Korea says finds ducks infected with bird flu

EVENTSreuters2016-03-28 12:23 Read   99

South Korea has detected bird flu in ducks on a poultry farm near Seoul, an agriculture ministry official told Reuters on Monday, the first discovery in four months and a month after the country regained its bird flu-free status.

Chinese authorities arrest more than 130 people in relation to vaccine scandal

EVENTSFirstword2016-03-28 10:25 Read   173

Officials in China have opened 69 cases against more than 130 people in relation to the sale of illegal vaccines across the country.

Naloxone now available in BC without a prescription

EVENTSfirstword2016-03-25 11:03 Read   181

"It was important to make this life-saving drug more widely available in British Columbia. The College worked closely with government and other stakeholders to bring non-prescription naloxone to BC quickly.

China detains 37 people linked to vaccine scandal: Xinhua

EVENTSxinhua2016-03-23 13:39 Read   125

Chinese police have detained 37 people linked to a vaccine scandal and are investigating three pharmaceutical companies, state news agency Xinhua reported on Wednesday.